TriLastin looks to stretch distribution
This article was originally published in The Rose Sheet
Executive Summary
EC Research "hope[s] to have broader distribution" in 2008 for its TriLastin-SR stretch-mark cream, sales of which surged 60 percent in 2007 compared with the year before, the firm says. Introduced online in 2005, TriLastin-SR has "posted sales throughout 130 countries" and now is available at A Pea in the Pod and Destination Maternity. The product's success has been "fueled by personal testimonials and recommendations," according to EC Research President Greg Cellini. Formulated with "high-potency" elastin, collagen and soy protein, TriLastin-SR "helps to prevent the breakdown of dermal tissues that causes stretch marks but also provides the necessary proteins to help repair existing marks." Firm says product "normalizes" stretch marks via a two-phased delivery system in which "de-hydrated microspheres attract moisture and rehydrate in the epidermis while a virtual 'skin patch' of marine collagen protects the skin and delivers nourishing compounds." EC Research says it aspires to grow the Trilastin brand to address a range of dermal imperfections...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.